Merck & Co. Inc (6MK DU) stock market data APIs
€80.923
-0.43(-0.5%)
as of November 14, 2025
Try our APIs with
free plan!
Merck & Co. Inc Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for 6MK.DU.
Prev. Close
80.923
Open
80.4976
High
80.923
Low
78.7868
52 wk Range
64.232-95.8195
Market Cap
162 424 M
Dividends (Yield)
0.0233
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Merck & Co. Inc data using free add-ons & libraries
Get Merck & Co. Inc Fundamental Data
Merck & Co. Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-30
- EPS/Forecast: 2.35
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Merck & Co. Inc News
New
Merck to buy Cidara for $9.2B, Netflix nears 10-for-1 stock split
Yahoo Finance host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute, including tech names Nvidia (NVDA), Tesla (TSLA), and Broadcom (AVGO) in recovery mode...
Merck Is Paying Up for Flu Biotech as M&A Spree Continues
Merck has agreed to pay a hefty premium for a biotech making a new flu prevention drug, as it braces for the expiration of the patents protecting its top-selling cancer treatment Keytruda. It is the l...
WBD amends CEO Zaslav's contract, StubHub withholds Q4 guidance
Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including Merck (MRK) pursuing an acquisition of Cidara Therapeutics (CDTX) in a deal valued at $9.2 billion, ...
Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal
Cidara Therapeutics shares doubled, and then some, on Friday after Merck agreed to buy the biotech company for $9.2 billion. Continue Reading 查看留言
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
